Fabino Enterprises Ltd
Incorporated in 2011, Fabino Enterprises manufactures, markets, trades, and does packing of pharmaceutical and other wellness focused consumer products[1]
- Market Cap ₹ 5.20 Cr.
- Current Price ₹ 24.8
- High / Low ₹ 36.5 / 22.8
- Stock P/E 40.0
- Book Value ₹ 20.4
- Dividend Yield 0.00 %
- ROCE 7.16 %
- ROE 3.08 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 277 to 177 days.
- Company's working capital requirements have reduced from 277 days to 103 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 1.52% over last 3 years.
- Company has high debtors of 177 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 2.76 | 7.52 | 3.06 | 4.19 | 3.36 | 6.01 | 18.04 | |
| 2.44 | 7.20 | 2.99 | 4.09 | 3.33 | 6.19 | 17.87 | |
| Operating Profit | 0.32 | 0.32 | 0.07 | 0.10 | 0.03 | -0.18 | 0.17 |
| OPM % | 11.59% | 4.26% | 2.29% | 2.39% | 0.89% | -3.00% | 0.94% |
| 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.29 | 0.29 | |
| Interest | 0.29 | 0.20 | 0.01 | 0.01 | 0.01 | 0.02 | 0.13 |
| Depreciation | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.07 |
| Profit before tax | 0.00 | 0.10 | 0.04 | 0.07 | 0.01 | 0.06 | 0.26 |
| Tax % | 30.00% | 25.00% | 28.57% | 0.00% | 16.67% | 50.00% | |
| 0.00 | 0.07 | 0.03 | 0.05 | 0.01 | 0.05 | 0.13 | |
| EPS in Rs | 0.00 | 4.67 | 0.25 | 0.24 | 0.05 | 0.24 | 0.62 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 63% |
| TTM: | 200% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 13% |
| 3 Years: | 38% |
| TTM: | 160% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -3% |
| 1 Year: | -12% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | 2% |
| Last Year: | 3% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.15 | 0.15 | 1.20 | 2.10 | 2.10 | 2.10 | 2.10 |
| Reserves | 0.45 | 0.52 | 0.10 | 2.00 | 2.01 | 2.06 | 2.19 |
| 2.52 | 1.08 | 0.31 | 0.05 | 0.41 | 0.84 | 1.61 | |
| 5.43 | 1.83 | 0.65 | 0.48 | 0.50 | 4.50 | 7.11 | |
| Total Liabilities | 8.55 | 3.58 | 2.26 | 4.63 | 5.02 | 9.50 | 13.01 |
| 0.10 | 0.08 | 0.16 | 0.17 | 0.15 | 0.24 | 0.46 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.05 |
| 8.45 | 3.50 | 2.10 | 4.46 | 4.87 | 9.21 | 12.50 | |
| Total Assets | 8.55 | 3.58 | 2.26 | 4.63 | 5.02 | 9.50 | 13.01 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 0.18 | 2.44 | -0.45 | -1.90 | -0.68 | -0.46 | -0.12 | |
| -0.01 | 0.00 | -0.10 | -0.05 | -0.01 | -0.18 | -0.41 | |
| -0.18 | -2.37 | 0.45 | 2.47 | 0.34 | 0.43 | 0.73 | |
| Net Cash Flow | 0.00 | 0.07 | -0.10 | 0.52 | -0.35 | -0.22 | 0.20 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 338.55 | 113.09 | 158.64 | 125.44 | 274.84 | 377.75 | 177.04 |
| Inventory Days | 988.71 | 15.36 | 62.61 | 174.83 | 147.24 | 83.99 | 26.56 |
| Days Payable | 1,024.81 | 77.34 | 63.94 | 34.76 | 45.78 | 279.12 | 152.06 |
| Cash Conversion Cycle | 302.45 | 51.11 | 157.31 | 265.51 | 376.29 | 182.62 | 51.53 |
| Working Capital Days | 334.58 | 51.93 | 165.80 | 292.70 | 444.30 | 282.40 | 102.99 |
| ROCE % | 12.32% | 2.98% | 2.78% | 0.46% | 1.68% | 7.16% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
29 May - Resignation of Company Secretary Ms. Kanchi Gehlot effective May 29, 2025, due to personal reasons.
-
Announcement under Regulation 30 (LODR)-Change in Management
29 May - Appointment of Secretarial and Internal Auditors for FY 2025-26 and 2026-27.
- Results For The Financial Year Ended March 31, 2025 29 May
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, May 29, 2025
29 May - Fabino Enterprises approved FY25 audited results; appointed secretarial and internal auditors; company secretary resigned.
-
Board Meeting Intimation for Meeting Dated May 29, 2025
26 May - Board meeting on May 29 to approve FY25 results and appoint auditors for FY26-27.
Business Overview:[1][2]
a) FEL is an ISO 9001:2015 pharmaceutical company located near the Delhi NCR region. It offers a wide range of allopathic and herbal products.
b) Company markets pharmaceutical formulation for domestic market and sells through own distribution network and sales force under
their own brand name
c) It gets Ayurvedic formulations manufactured through Loan Licensing facilities, Packing, Labelling etc.
d) Company exports wellness and FMCG products like Coffee, Malt powder, Protein powder, Hair shampoo which it also markets